Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
AstraZeneca
Deloitte
McKesson
Harvard Business School

Generated: March 22, 2019

DrugPatentWatch Database Preview

KANAMYCIN SULFATE - Generic Drug Details

« Back to Dashboard

What are the generic sources for kanamycin sulfate and what is the scope of kanamycin sulfate patent protection?

Kanamycin sulfate is the generic ingredient in four branded drugs marketed by Apothecon, West-ward Pharms Int, Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Loch, Pharmafair, Solopak, Warner Chilcott, Watson Labs, and King Pharms, and is included in twenty NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for kanamycin sulfate.

Summary for KANAMYCIN SULFATE
US Patents:0
Tradenames:4
Applicants:11
NDAs:20
Drug Master File Entries: 5
Bulk Api Vendors: 72
Patent Applications: 210
DailyMed Link:KANAMYCIN SULFATE at DailyMed
Medical Subject Heading (MeSH) Categories for KANAMYCIN SULFATE
Synonyms for KANAMYCIN SULFATE
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)te
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)tetrahydro-2H-pyran-3,4,5-triol sulfate
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; sulfuric acid
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid
(3R,4S,6S)-2-(aminomethyl)-6-[(1R,4S,6R)-4,6-bis(azanyl)-3-[(2R,4S,5R)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol; sulfuric acid
(3R,4S,6S)-2-(aminomethyl)-6-[(1R,4S,6R)-4,6-diamino-3-[[(2R,4S,5R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; sulfuric acid
11030-21-0
11033-61-7
133-92-6
133K926
2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol; sulfuric acid
25389-94-0
3847-27-6
A817840
AC-20043
AC1L1OPO
AC1L9B21
AK163185
AKOS004910322
AKOS015951287
AKOS025310124
API0003073
API0003074
BIK0126
C08046
C18H36N4O11.H2O4S
C18H36N4O11.H2SO4
C18H38N4O15S
Cantrex
CAS-25389-94-0
CCG-220394
CHEBI:6109
CHEMBL1446
Cristalomicina
CS-1140
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-->4)]-2-deoxy-, sulfate (1:1)
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1->4))-2-deoxy-, sulfate (1:1) (salt)
D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl(1-4))-2-deoxy-, sulfate (1:1) (salt)
D00866
D03262
DSSTox_CID_27524
DSSTox_GSID_47524
DSSTox_RID_82394
DTXSID1047524
EINECS 223-347-1
EINECS 246-933-9
HMS1569O09
HMS2096O09
HMS3713O09
HMS500B06
HY-16566A
J10342
J80EX28SMQ
K0047
Kanabristol
Kanacedin
Kanamycin (sulfate)
Kanamycin A sulfate
Kanamycin A sulphate
Kanamycin acid sulfate
KANAMYCIN MONO SULPHATE
Kanamycin monosulfate
Kanamycin monosulfate (JP17)
Kanamycin monosulfate [JAN]
Kanamycin Monosulphate
Kanamycin sulfate (1:1) (salt)
Kanamycin sulfate (JP17)
Kanamycin sulfate (TN)
Kanamycin sulfate (USP)
Kanamycin sulfate [USAN:INN:BAN]
Kanamycin sulfate [USP:JAN]
Kanamycin sulfate from Streptomyces kanamyceticus, Animal Component-free
Kanamycin sulfate from Streptomyces kanamyceticus, meets USP testing specifications, powder
Kanamycin sulfate from Streptomyces kanamyceticus, powder, BioReagent, suitable for cell culture, suitable for plant cell culture
Kanamycin sulfate salt
Kanamycin sulfate Streptomyces kanamyceticus, powder, gamma-irradiated
Kanamycin sulfate, mixture of Kanamycin A (main component) and Kanamycin B and C
Kanamycin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
Kanamycin sulphate
KANAMYCIN, SULFATE (1:1) (salt)
kanamycin; sulfuric acid
Kanamytrex
Kanaqua
Kanasig
Kanatrol
Kanescin
Kanicin
Kannasyn
Kano
Kantrex (TN)
Kantrim
Klebcil
Knamycin A sulfate
KSC-27-052C
KUC109575AC
LS-86962
MolPort-005-938-424
MolPort-006-069-166
NCGC00016792-01
NCGC00260363-01
O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine Monosulfate
OOYGSFOGFJDDHP-KMCOLRRFSA-N
Ophtalmokalixan
Otokalixin
Prestwick_596
s2315
SCHEMBL17913127
SCHEMBL65538
ST24047464
Tox21_110612
Tox21_202817
trahydro-2H-pyran-3,4,5-triol sulfate
UNII-J80EX28SMQ
UNII-OW1N4G4R9W component OOYGSFOGFJDDHP-KMCOLRRFSA-N
W-5066
ZX-AFC000777

US Patents and Regulatory Information for KANAMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 062564-001 Sep 21, 1984 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Solopak KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 062605-002 Feb 26, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Loch KANAMYCIN SULFATE kanamycin sulfate INJECTABLE;INJECTION 063021-001 Jul 31, 1992 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Chubb
Chinese Patent Office
Federal Trade Commission
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.